Previous 10 | Next 10 |
CORAL GABLES, Fla., Sept. 25, 2019 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, tod...
Yesterday, Catalyst Pharmaceuticals (NASDAQ: CPRX) , a small-cap orphan drugmaker, saw its shares tumble by as much as 20% on sky-high volume. This sizable downturn, in kind, prompted the company to issue a press release toward the end of the day's trading session essentially stating that...
Catalyst Pharmaceuticals ( CPRX -15.6% ) slumps on more than a 4x surge in volume on no apparent news. In a statement, the company says it is "not aware" of any information that would account for the bearish action. More news on: Catalyst Pharmaceuticals, Inc., Healthcare stocks news, St...
CORAL GABLES, Fla., Sept. 23, 2019 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (NasdaqCM: CPRX) is commenting on today's trading activity in its common stock and on the current state of its capital resources. The Company is reporting that it is not aware of any informa...
Gainers: Interlink Electronics ( OTCPK:LINK ) +37% . Avadel Pharmaceuticals plc (NASDAQ: AVDL ) +33% . Arotech Corporation (NASDAQ: ARTX ) +31% . Plus Therapeutics (NASDAQ: PSTV ) +25% . Cesca Therapeutics (NASDAQ: KOOL ) +20% . PriceSmart (NASDAQ: PSMT ) +18% . Dova Pharmaceuticals...
Introduction The Weekly Breakout Forecast continues my doctoral research analysis on MDA breakout selections over more than 5 years. This subset of the different portfolios I regularly analyze has now reached 120 weeks of public selections as part of this ongoing live forward-testing. In...
BDSI kicked off the post-Labor Day investing season with two investor conference appearances and clinical presentations at the medical conference PainWeek. We participated in the investor conferences enabling us to revisit our fundamental thesis and get an update on the company. Like our follo...
Biotech stocks rarely perform well during the summer months, and 2019 has proven to be no exception in regards to this historical trend line. The iShares Nasdaq Biotechnology ETF , for example, has now fallen by nearly 2% since the official start of summer. Biotech equities, however, d...
Mer Telemanagement Solutions (NASDAQ: MTSL ) +96% on 1H results . More news on: Mer Telemanagement Solutions Ltd., Fibrocell Science, Inc., Cellectar Biosciences, Inc., Stocks on the move, Read more ...
Catalyst Pharmaceuticals (NASDAQ: CPRX ) is up 10% premarket on the heels of the announcement to terminate its common stock offering. More news on: Catalyst Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Catalyst Pharmaceuticals Inc. Company Name:
CPRX Stock Symbol:
NASDAQ Market:
Catalyst Pharmaceuticals Inc. Website:
CORAL GABLES, Fla., July 22, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-...
2024-06-20 17:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-03 11:30:04 ET H.C. Wainwright analyst issues UNDERPERFORM recommendation for CPRX on June 3, 2024 09:00AM ET. The previous analyst recommendation was Underperform. CPRX was trading at $16.38 at issue of the analyst recommendation. The overall analyst consensus :...